Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05

Veronique Dieras, Giuseppe Curigliano, Miguel Martin, Florence Lerebours, Junji Tsurutani, Marie-France Savard, Katarzyna J. Jerzak, Xichun Hu, Luciana Carla Martins de Aquino Pimentel, Ciara C. O’Sullivan, Eriko Tokunaga, Alicia Okines, Chiun-Sheng Huang, William Jacot, Joohyuk Sohn, Eduardo Cronemberger Silva, Volkmar Muelle, Shan Yang, Giovanna Granata, Qi Shen, Erika Hamilton

Open source

DOI: 10.1080/14796694.2026.2753928
Published: 2026-11-06
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2753928,
  title = {Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05},
  author = {Veronique Dieras and Giuseppe Curigliano and Miguel Martin and Florence Lerebours and Junji Tsurutani and Marie-France Savard and Katarzyna J. Jerzak and Xichun Hu and Luciana Carla Martins de Aquino Pimentel and Ciara C. O’Sullivan and Eriko Tokunaga and Alicia Okines and Chiun-Sheng Huang and William Jacot and Joohyuk Sohn and Eduardo Cronemberger Silva and Volkmar Muelle and Shan Yang and Giovanna Granata and Qi Shen and Erika Hamilton},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2753928},
  url = {https://doi.org/10.1080/14796694.2026.2753928}
}

RIS

TY  - JOUR
TI  - Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05
AU  - Veronique Dieras
AU  - Giuseppe Curigliano
AU  - Miguel Martin
AU  - Florence Lerebours
AU  - Junji Tsurutani
AU  - Marie-France Savard
AU  - Katarzyna J. Jerzak
AU  - Xichun Hu
AU  - Luciana Carla Martins de Aquino Pimentel
AU  - Ciara C. O’Sullivan
AU  - Eriko Tokunaga
AU  - Alicia Okines
AU  - Chiun-Sheng Huang
AU  - William Jacot
AU  - Joohyuk Sohn
AU  - Eduardo Cronemberger Silva
AU  - Volkmar Muelle
AU  - Shan Yang
AU  - Giovanna Granata
AU  - Qi Shen
AU  - Erika Hamilton
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2753928
UR  - https://doi.org/10.1080/14796694.2026.2753928
ER  -

APA

Dieras, V., Curigliano, G., Martin, M., Lerebours, F., Tsurutani, J., Savard, M., Jerzak, K. J., Hu, X., Pimentel, L. C. M. D. A., O’Sullivan, C. C., Tokunaga, E., Okines, A., Huang, C., Jacot, W., Sohn, J., Silva, E. C., Muelle, V., Yang, S., Granata, G., Shen, Q., & Hamilton, E. (2026). Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05. Future Oncology. https://doi.org/10.1080/14796694.2026.2753928

Source records

crossref · retrieved 2026-11-08T07:08:37.118Z